Abstract
A 19-year-old Caucasian male presented with complaints of headaches and syncope. Suspicion of hydrocephalus prompted computed tomography (CT) and magnetic resonance imaging (MRI), which revealed pineal and suprasellar prominences with diffuse, thick, nodular subependymal enhancement of the lateral and third ventricles. Based on imaging, the differential diagnosis consisted primarily of malignancy, such as lymphoma, with inflammatory and infectious etiologies not excluded. Cerebrospinal fluid (CSF) samples were non-specific, and neuroendoscopic tissue biopsy histologically confirmed the diagnosis of pure germinoma. The patient was treated with radiation, and follow-up MRIs at one, three, six, and 12 months demonstrated progressive resolution of tumor burden with marked clinical improvement.
Germinomas are rare germ cell tumors that are more frequently diagnosed in Asian countries. They uncommonly seed into the lateral ventricles, and only two other cases have been described with diffuse subependymal involvement. Unlike other malignant germ cell tumors, germinomas have marker negative CSF samples that are important in the normal diagnostic workup of diffuse subependymal lesions. Histopathologic correlation is required for definitive diagnosis in the United States and can be achieved with endoscopic tissue sampling. Germinomas are highly radio- and chemotherapy sensitive and have a fair prognosis with modern therapeutic techniques. Germinoma should be considered with simultaneous midline and diffuse ventricular lesions.
Keywords: intracranial germinoma, diffuse subependymal, ventricles, suprasellar, pineal
Introduction
The World Health Organization (WHO) categorizes central nervous system (CNS) germ cell tumors (GCTs) as non-germinomas and germinomas [1]. While rare, germinomas are the most common GCT composing 36 - 70% of all cases [2-10]. The incidence of CNS GCTs varies significantly according to geography, accounting for 0.1 - 3.4% of all primary brain tumors in Western countries [2-3, 6, 11-14]. In the United States, the estimated incidence of intracranial germinoma is 0.1/100,000 persons [15], and in Canada, the incidence is 1.06/1,000,000 for those less than 19 years old [3]. In Asian countries, the incidence of CNS GCTs dramatically increases to between 4.8% and 15% of intracranial neoplasms [6, 16-22]. Germinomas have a male to female ratio of 1.8 - 3.5:1, and are diagnosed at a mean age of 11.6 - 12.3 years old [3, 6].
Clinical presentation is variable and dictated by tumor location. A careful history and physical exam detailing any endocrine, circadian rhythm, and cranial nerve abnormalities, as well as symptoms of increased intracranial pressure, is helpful. Germinomas typically present in the pineal (38 - 57%) or suprasellar regions (34 - 49%), less frequently as a double lesion in the pineal and suprasellar regions synchronously (5-10%), and rarely in other locations (3-5%), including the ventricles [2-3, 6, 23-25]. GCTs have inconsistent radiographic appearances [3, 26-29]. A retrospective analysis of 18 separate cases of germinomas showed all tumors had solid components that enhanced homogeneously in eight (44%) cases and heterogeneously in 10 (56%) cases while eight (44%) cases had cystic components [28].
Case presentation
A 19-year-old Caucasian male presented to an outside emergency department with a variety of non-specific symptoms, including severe headaches with resultant emesis and syncopal episodes. A review of systems was otherwise essentially negative for constitutional, neurological, and endocrine symptoms. There was no history of prior meningitis, frequent infections, familial cancers, or high-risk behaviors, such as illicit drug usage. The patient's vitals were stable and extensive lab workup was normal, but fundoscopic examination showed optic pallor bilaterally. A computed tomography scan (CT) was ordered for suspected hydrocephalus, which demonstrated a transependymal fluid shift with enlargement of the lateral and third ventricles with nodular densities prominent in the occipital and anterior horns bilaterally (Figure 1). Informed patient consent was obtained for treatment.
Figure 1. Non-contrast-enhanced CT head at initial presentation.
There is transependymal fluid shift with enlargement of the lateral and third ventricles with nodular densities prominent in the occipital and anterior horns bilaterally.
A right occipital ventriculoperitoneal shunt was placed and cerebrospinal fluid (CSF) samples were sent for cytology with the suspicion of an underlying malignancy, such as lymphoma, inflammatory, or infectious etiology. CSF samples showed a non-specific reactive T-cell lymphocytosis but were otherwise unremarkable for tumor and inflammatory markers, including for alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin (β-hCG).
The patient was then evaluated at a tertiary center where a right frontal endoscopic biopsy was undertaken for definitive diagnosis. Preoperative magnetic resonance imaging (MRI) confirmed extensive subependymal enhancement in a thick, nodular pattern diffusely throughout both lateral ventricles and the pineal region as well as the diffuse involvement of the third ventricle, including the foramen of Monro, suprasellar region, and Sylvian aqueduct, with moderate ventricular and aqueduct dilatation (Figure 2).
Figure 2. Post-contrast axial and sagittal MRI sequences with neuronavigation protocol at diagnosis.
There is diffuse involvement of the lateral and third ventricles, the suprasellar and pineal regions, and the aqueduct with resultant ventriculomegaly.
Tissue samples taken from the right frontal horn of the lateral ventricle were once again negative for AFP and β-hCG but positive for cytoplasmic placental-like alkaline phosphatase (PLAP), confirming the diagnosis of pure CNS germinoma.
The patient was treated with 25.4 Gy radiation to the cranial-spinal axis due to the significant intracranial spread, 36 Gy total whole brain radiation, and 50.4 Gy (in 1.8 Gy or fewer fractions) boosts to the prominent midline and ventricular regions. Follow-up MRIs at one, three, six, and 12 months demonstrated diminishing tumor burden with mild residual lateral ventriculomegaly (Figure 3).
Figure 3. Post-contrast axial and sagittal MRI sequences one year after diagnosis and initiation of radiation therapy.
There is resolution of tumor burden with mild residual ventriculomegaly.
At his last visit, the patient was asymptomatic with a resolution of his syncopal episodes and headaches.
Discussion
This patient’s imaging characteristics were not typical of any particular lesion; therefore, neoplastic, inflammatory, and infectious etiologies all needed to be considered. For the patient’s age and diffuse subependymal involvement of the lateral and third ventricles, lymphoma and metastasis were the main concern. The differential for masses of the ventricular system is vast, and when including the pineal and suprasellar regions as well, the possibilities are immense [30-32]. Germinoma was a far less likely possibility, given the geographic presentation, radiographic appearance, and a few cases in the literature of diffuse subependymal involvement [29, 33-34].
CNS GCTs are categorized based on secreted tumor markers that are most sensitive and reliably measured in CSF [1, 35]. Yolk sac tumors and choriocarcinomas often present with AFP and β-hCG elevation, respectively, while the marker negative CSF samples obtained in our case were suggestive of a diagnosis of germinoma [36]. Current screening controversies surround the sensitivity of CSF sampling and whether ≤ 50 mIU/L CSF β-hCG or ≤ 200 mIU/L CSF β-hCG should be suggestive of a pure germinoma [26]. While CSF sampling and radiographic imaging are helpful, GCTs ultimately require tissue sampling for diagnosis in the United States [26, 29, 37]. Tissues that stain positive for PLAP is pathognomonic for germinoma.
Intracranial germinomas are highly curable tumors with a fair prognosis despite being WHO Grade IV lesions and rapidly fatal, if untreated [1]. Radiation and chemotherapy results in a five-year progression-free survival of 83 - 100% and an overall survival of 89 - 100% [1, 38-39]. A nonrandomized international study for intracranial germinomas comparing craniospinal irradiation versus chemotherapy, plus local radiotherapy, showed there were no differences in five-year event-free overall survival, although the radiotherapy alone arm had improved progression-free survival [40]. The optimal treatment modality remains controversial, and future directions will continue to focus on balancing adverse effects with curative goals [26].
A review of the English literature demonstrated only 17 other reported cases of a germinoma in the lateral ventricles, with a majority of these cases occurring in Asian countries. However, many of these cases had involvement of the ventricles only (Table 1A) [23, 41-44], a presumed midline epicenter involving the lateral ventricles only (Table 1B) [42, 45], reoccurrence along a shunt tube (Table 1C) [46], a presumed midline epicenter with non-diffuse involvement of one or multiple ventricles (Table 1D) [42, 47-49], or a non-pure germinoma with diffuse subependymal involvement (Table 1E) [29]. In 2012, Chen, et al. described their therapeutic experiences treating disseminated germinomas in an Asian country and mentioned two cases involving seeding in multiple ventricles [39]. Although the differences were subtle, we were only able to find two other cases in the literature of a pure intracranial germinoma with extensive seeding of the lateral and third ventricles; however, those cases also involved extensive metastasis resulting in death (Table 1F) [33-34]. Therefore, this case (Table 1G) importantly represents an exceedingly rare occurrence in a Western country of a potentially curable neoplasm that should be included in a differential diagnosis in cases of midline anomalies with diffuse subependymal involvement.
Table 1. English Literature Germinoma in the Lateral Ventricles.
Group A: Germinoma in lateral and other ventricles. Group B: Germinoma in lateral ventricles only with midline epicenter. Group C: Germinoma recurrence along shunt tract. Group D: Germinoma with midline epicenter and non-diffuse involvement of one or multiple ventricles. Group E: Non-pure germinoma with diffuse subependymal involvement. Group F: Pure germinoma with diffuse seeding in lateral and third ventricles resulting in death. Group G: present case.
| Group | Reference | Age, Sex | Race | Country | Imaging | Primary | Dissemination | Outcome |
| A | [44] | 19, M | - | Japan | Heterogeneous, Enhancing | Septum Pellucidum | Left Lateral Ventricle, Basal Ganglia | - |
| A | [41] | - | - | South Korea | - | - | Lateral and Third Ventricles | - |
| A | [42] | 28, M | - | Japan | - | Lateral Ventricle | - | No reoccurrence at 13 years |
| A | [42] | 30, M | - | Japan | - | Lateral Ventricle | Third and Fourth Ventricles | No reoccurrence at 7 years |
| A | [23] | 13, M | - | South Korea | - | Septum | Frontal Horn Lateral Ventricle | No reoccurrence at 10 years |
| A | [43] | 25, F | - | Taiwan | Enhancing | Right Frontal Horn Lateral Ventricle | Septum Pellucidum | No reoccurrence at 6 months |
| B | [42] | 18, M | - | Japan | - | Pineal Gland | Lateral Ventricle | No reoccurrence at 13 years |
| B | [45] | 27, M | - | Japan | Low-intensity T1, High-intensity T2, Enhancing | Intraparenchymal | Lateral Ventricle | No reoccurrence at 1 year |
| C | [46] | 38, M | - | Japan | - | Suprasellar | Lateral Ventricle | Reoccurrence at 5 years, twice between years 6 and 7 |
| D | [48] | 23, M | Caucasian | Germany | Circumscribed, Multifocal, Homogenously Enhancing | Midline | Anterior Horns Lateral Ventricles | No reoccurrence at 3 months |
| D | [42] | 18, M | - | Japan | - | Suprasellar | Basal Ganglia, Lateral Ventricle | No reoccurrence at 6 years |
| D | [42] | 19, M | - | Japan | - | Midline | Lateral Ventricle | No reoccurrence at 5 years |
| D | [49] | 33, M | African American | United States | Enhancing | Midline | Left Anterior Horn of Lateral Ventricle, Floor of Fourth Ventricle | No reoccurrence at 1 year |
| D | [47] | 17, F | - | United States | Hypointense on T2, Enhancing | Midline | Right Frontal Horn of Lateral Ventricle | No reoccurrence at 1 year |
| E | [29] | 18, M | - | United States | Well-delineated, Hyperdense, Enhancing | Midline | Diffuse. Lateral and Third Ventricles | No reoccurrence at 4 years |
| F | [33] | 24, M | - | United States | Enhancing | - | Meninges, Diffuse Lateral, and Third Ventricles | Death |
| F | [34] | 23, F | - | India | - | Midline | Diffuse Lateral Ventricle and Third Ventricle; Caudate, Fornix, Optic Chiasm, Optic Nerve | Death |
| G | Present Case | 19, M | Caucasian | United States | Enhancing | Midline | Lateral and Third Ventricles | No reoccurrence at 12 months |
Conclusions
In conclusion, intracranial germinomas are uncommon tumors that primarily affect adolescent males in Asian countries. We present a rare case in a Western country of a pure germinoma in the pineal and suprasellar regions with the atypical radiographic appearance of diffuse spread to the lateral and third ventricles. Unlike other malignant germ cell tumors, germinomas have marker-negative CSF samples that are important in the normal diagnostic workup of diffuse subependymal lesions. Histopathologic correlation is required for definitive diagnosis in the United States and can be achieved with endoscopic tissue sampling. Germinomas are highly radio- and chemotherapy-sensitive and have a fair prognosis with modern therapeutic techniques. A germinoma should be considered with simultaneous midline and diffuse ventricular lesions.
Acknowledgments
Ajeet Gordhan M.D., Amit Vyas M.D., and the Advocate Health Care Research Committee assisted in revision of this manuscript.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained by all participants in this study
References
- 1.The 2007 WHO classification of tumours of the central nervous system. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. Acta Neuropathol. 2007;114:97–109. doi: 10.1007/s00401-007-0243-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Intracranial germ cell tumors. Packer RJ, Cohen BH, Cooney K. http://theoncologist.alphamedpress.org/content/5/4/312.full. Oncologist. 2000;5:312–320. [PubMed] [Google Scholar]
- 3.Epidemiological survey of central nervous system germ cell tumors in Canadian children. Keene D, Johnston D, Strother D, Fryer C, Carret AS, Crooks B, Eisenstat D, Moghrabi A, Wilson B, Brossard J, Mpofu C, Odame I, Zelcer S, Silva M, Samson Y, Hand J, Bouffet E; Canadian Pediatric Brain Tumor Consortium. J Neurooncol. 2007;82:289–295. doi: 10.1007/s11060-006-9282-2. [DOI] [PubMed] [Google Scholar]
- 4.Descriptive epidemiology of central nervous system germ cell tumors: nonpineal analysis. Villano JL, Virk IY, Ramirez V, Propp JM, Engelhard HH, McCarthy BJ. Neuro Oncol. 2010;12:257–264. doi: 10.1093/neuonc/nop029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Intracranial germ cell tumors: pathobiological and immunohistochemical aspects of 70 cases. Bjornsson J, Scheithauer BW, Okazaki H, Leech RW. http://www.pubfacts.com/detail/4038412/Intracranial-germ-cell-tumors-pathobiological-and-immunohistochemical-aspects-of-70-cases. J Neuropathol Exp Neurol. 1985;44:32–46. [PubMed] [Google Scholar]
- 6.Intracranial germ-cell tumors: natural history and pathogenesis. Jennings MT, Gelman R, Hochberg F. J Neurosurg. 1985;63:155–167. doi: 10.3171/jns.1985.63.2.0155. [DOI] [PubMed] [Google Scholar]
- 7.Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O, Funata N, Seto T. J Neurosurg. 1997;86:446–455. doi: 10.3171/jns.1997.86.3.0446. [DOI] [PubMed] [Google Scholar]
- 8.Pathogenesis of intracranial germ cell tumors reconsidered. Sano K. J Neurosurg. 1999;90:258–264. doi: 10.3171/jns.1999.90.2.0258. [DOI] [PubMed] [Google Scholar]
- 9.Histologically confirmed pineal tumors and other germ cell tumors of the brain. Schild SE, Scheithauer BW, Haddock MG, Wong WW, Lyons MK, Marks LB, Norman MG, Burger PC. Cancer. 1996;78:2564–2571. doi: 10.1002/(sici)1097-0142(19961215)78:12<2564::aid-cncr16>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
- 10.Diagnosis and management of pineal tumors. Jooma R, Kendall BE. J Neurosurg. 1983;58:654–665. doi: 10.3171/jns.1983.58.5.0654. [DOI] [PubMed] [Google Scholar]
- 11.Experience with pineal region tumours in childhood. Hoffman HJ, Yoshida M, Becker LE, Hendrick EB, Humphreys RP. Neurol Res. 1984;6:107–112. doi: 10.1080/01616412.1984.11739672. [DOI] [PubMed] [Google Scholar]
- 12.Pineal and suprasellar germinomas. Results of radiation treatment. Jenkin RD, Simpson WJ, Keen CW. J Neurosurg. 1978;48:99–107. doi: 10.3171/jns.1978.48.1.0099. [DOI] [PubMed] [Google Scholar]
- 13.Germinal neoplasms of the central nervous system. Nishiyama RH, Batsakis JG, Weaver DK, Simrall JH. Arch Surg. 1966;93:342–347. doi: 10.1001/archsurg.1966.01330020134023. [DOI] [PubMed] [Google Scholar]
- 14.Tumors of the pineal and suprasellar region: Childrens Cancer Study Group treatment results 1960--1975: a report from Childrens Cancer Study Group. Wara WM, Jenkin RD, Evans A, Ertel I, Hittle R, Ortega J, Wilson CB, Hammond D. Cancer. 1979;43:698–701. doi: 10.1002/1097-0142(197902)43:2<698::aid-cncr2820430243>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- 15.Central nervous system germinomas: a review. Horowitz MB, Hall WA. Arch Neurol. 1991;48:652–657. doi: 10.1001/archneur.1991.00530180110026. [DOI] [PubMed] [Google Scholar]
- 16.Intracranial germinoma: clinical and MRI findings in 56 patients. Wang Y, Zou L, Gao B. Childs Nerv Syst. 2010;26:1773–1777. doi: 10.1007/s00381-010-1247-2. [DOI] [PubMed] [Google Scholar]
- 17.Matsutani M, Takakura K, Sano K. Intracranial Tumors in Infancy and Childhood. Basic Research, Diagnosis and Treatment. (Progress in Experimental Tumor Research) Vol. 30. Basel: Karger; 1987. Primary intracranial germ cell tumors: Pathology and treatment; pp. 307–312. [DOI] [PubMed] [Google Scholar]
- 18.Pinealoma in children. Sano K. Childs Brain. 1976;2:67–72. doi: 10.1159/000119602. [DOI] [PubMed] [Google Scholar]
- 19.Intracranial germ cell tumors. Takakura K. Clin Neurosurg. 1985;32:429–444. [PubMed] [Google Scholar]
- 20.Intracranial germ-cell tumors in children. Hoffman HJ, Otsubo H, Hendrick EB, Humphreys RP, Drake JM, Becker LE, Greenberg M, Jenkin D. J Neurosurg. 1991;74:545–551. doi: 10.3171/jns.1991.74.4.0545. [DOI] [PubMed] [Google Scholar]
- 21.Primary intracranial germ cell tumours. Jellinger K. Acta Neuropathol. 1973;25:291–306. doi: 10.1007/BF00691757. [DOI] [PubMed] [Google Scholar]
- 22.Primary intracranial germ-cell tumor in children. Lin IJ, Shu SG, Chu HY, Chi CS. http://homepage.vghtpe.gov.tw/~jcma/6005/600505.htm. Chin Med J (Taipei) 1997;60:259–264. [PubMed] [Google Scholar]
- 23.Germinomas in the basal ganglia: magnetic resonance imaging classification and the prognosis. Phi JH, Cho BK, Kim SK, Paeng JC, Kim IO, Kim IH, Kim DG, Jung HW, Kim JE, Wang KC. http://www.brainlife.org/fulltext/2010/Phi_JH100120.pdf. J Neurooncol. 2010;99:227–236. doi: 10.1007/s11060-010-0119-7. [DOI] [PubMed] [Google Scholar]
- 24.Clinical management of primary central nervous system germ cell tumors. Matsutani M. Semin Oncol. 2004;31:676–683. doi: 10.1053/j.seminoncol.2004.07.010. [DOI] [PubMed] [Google Scholar]
- 25.Germinoma of medulla. Neelima R, Mathew A, Kapilamoorthy TR, Radhakrishnan VV. Neurol India. 2010;58:768–770. doi: 10.4103/0028-3886.72190. [DOI] [PubMed] [Google Scholar]
- 26.The management of patients with primary central nervous system (CNS) germinoma: current controversies requiring resolution. Finlay J, da Silva NS, Lavey R, Bouffet E, Kellie SJ, Shaw E, Saran F, Matsutani M. Pediatr Blood Cancer. 2008;51:313–316. doi: 10.1002/pbc.21555. [DOI] [PubMed] [Google Scholar]
- 27.Metachronous germinoma after total removal of mature teratoma in the third ventricle: a case report. Kim JM, Cheong JH, Yi HJ, Bak KH, Kim CH, Oh SJ. J Korean Med Sci. 2002;17:287–291. doi: 10.3346/jkms.2002.17.2.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.MRI of intracranial germ-cell tumours. Liang L, Korogi Y, Sugahara T, Ikushima I, Shigematsu Y, Okuda T, Takahashi M, Kochi M, Ushio Y. Neuroradiology. 2002;44:382–388. doi: 10.1007/s00234-001-0752-0. [DOI] [PubMed] [Google Scholar]
- 29.Pineal region tumors: computed tomographic-pathologic spectrum. Futrell NN, Osborn AG, Cheson BD. AJR Am J Roentgenol. 1981;137:951–956. doi: 10.2214/ajr.137.5.951. [DOI] [PubMed] [Google Scholar]
- 30.Unusual appearances of primary central nervous system non-Hodgkin's lymphoma. Gutmann J, Kendall B. Clin Radiol. 1994;49:696–702. doi: 10.1016/s0009-9260(05)82663-7. [DOI] [PubMed] [Google Scholar]
- 31.Lesions of the hypothalamus: MR imaging diagnostic features. Saleem SN, Said AH, Lee DH. Radiographics. 2007;27:1087–1108. doi: 10.1148/rg.274065123. [DOI] [PubMed] [Google Scholar]
- 32.Pineal region masses: differential diagnosis. Smirniotopoulos JG, Rushing EJ, Mena H. Radiographics. 1992;12:577–596. doi: 10.1148/radiographics.12.3.1609147. [DOI] [PubMed] [Google Scholar]
- 33.Germinoma-unusual presentation: a case report. Yang C, Jagjivan B, Rao K. Conn Med. 2004;68:617–619. [PubMed] [Google Scholar]
- 34.Subarachnoid spread of germinoma mimicking tuberculous meningitis. Suresh TN, Mahadevan A, Santosh V, Shankar SK. http://www.neurologyindia.com/article.asp?issn=0028-3886;year=2004;volume=52;issue=2;spage=251;epage=253;aulast=Suresh. Neurol India. 2004;52:251–253. [PubMed] [Google Scholar]
- 35.Pediatric central nervous system germ cell tumors: a review. Echevarría ME, Fangusaro J, Goldman S. Oncologist. 2008;13:690–699. doi: 10.1634/theoncologist.2008-0037. [DOI] [PubMed] [Google Scholar]
- 36.AFP/β-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. Calaminus G, Bamberg M, Harms D, Jürgens H, Kortmann RD, Sörensen N, Wiestler OD, Göbel U. Neuropediatrics. 2005;36:71–77. doi: 10.1055/s-2005-837582. [DOI] [PubMed] [Google Scholar]
- 37.Refining the staging evaluation of pineal region germinoma using neuroendoscopy and the presence of preoperative diabetes insipidus. Reddy AT, Wellons JC 3rd, Allen JC, Fiveash JB, Abdullatif H, Braune KW, Grabb PA. Neuro Oncol. 2004;6:127–133. doi: 10.1215/S1152851703000243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Radiation therapy for intracranial germ cell tumors. Haas-Kogan DA, Missett BT, Wara WM, Donaldson SS, Lamborn KR, Prados MD, Fisher PG, Huhn SL, Fisch BM, Berger MS, Le QT. Int J Radiat Oncol Biol Phys. 2003;56:511–518. doi: 10.1016/s0360-3016(02)04611-4. [DOI] [PubMed] [Google Scholar]
- 39.Treatment strategies for initially disseminated intracranial germinomas: experiences at a single institute. Chen YW, Huang PI, Hu YW, Ho DM, Chang KP, Guo WY, Chang FC, Lee YY, Shiau CY, Wong TT, Yen SH. Childs Nerv Syst. 2012;28:557–563. doi: 10.1007/s00381-012-1683-2. [DOI] [PubMed] [Google Scholar]
- 40.SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Calaminus G, Kortmann R, Worch J, Nicholson JC, Alapetite C, Garrè ML, Patte C, Ricardi U, Saran F, Frappaz D. Neuro Oncol. 2013;15:788–796. doi: 10.1093/neuonc/not019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Surgery of the tumors in the ventricular system. Hong SW, Choi HY, Koh EJ. http://www.jkns.or.kr/htm/fulltext.asp?no=0042006005 J Korean Neurosurg Soc. 2006;39:26–31. [Google Scholar]
- 42.Results of a long-term follow-up after neuroendoscopic biopsy procedure and third ventriculostomy in patients with intracranial germinomas. Shono T, Natori Y, Morioka T, Torisu R, Mizoguchi M, Nagata S, Suzuki SO, Iwaki T, Inamura T, Fukui M, Oka K, Sasaki T. J Neurosurg. 2007;107:193–198. doi: 10.3171/PED-07/09/193. [DOI] [PubMed] [Google Scholar]
- 43.Neuroendoscopic management of intraventricular germinoma at the foramen of Monro: case report and review of the literature. Yip CM, Hsu SS, Liao WC, Chen JY, Liu SH, Chen CH. Minim Invasive Neurosurg. 2011;54:191–195. doi: 10.1055/s-0031-1285887. [DOI] [PubMed] [Google Scholar]
- 44.A case of germinoma in the septum pellucidum manifesting as amnesia and hemiparesis. Sato K, Nagayama T, Fujimura M, Okamoto K, Kamiya M, Nakazato Y. Acta Neurochir (Wien) 2003;145:923–926. doi: 10.1007/s00701-003-0110-6. [DOI] [PubMed] [Google Scholar]
- 45.Navigation-guided endoscopic biopsy for pathological diagnosis for intraparenchymal pure germinoma near the ventricular trigone. Onuma K, Ishikawa E, Matsuda M, Shibata Y, Satomi K, Yamamoto T, Zaboronok A, Takano S, Matsumura A. http://surgicalneurologyint.com/surgicalint_articles/navigation-guided-endoscopic-biopsy-for-pathological-diagnosis-for-intraparenchymal-pure-germinoma-near-the-ventricular-trigone/ Surg Neurol Int. 2012;3:9. doi: 10.4103/2152-7806.92177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Recurrent intracranial germinoma with dissemination along the ventricular catheter: a case report. Shima H, Nishizaki T, Ishihara H, Moroi J, Fujii M, Suzuki M. J Clin Neurosci. 2002;9:708–710. doi: 10.1054/jocn.2001.1068. [DOI] [PubMed] [Google Scholar]
- 47.Pearls & Oy-sters: Bifocal germinoma of the brain: review of systems is key to the diagnosis. Ghosh PS, Tekautz T, Mitra S. Neurology. 2012;78:0–10. doi: 10.1212/WNL.0b013e31823efc5a. [DOI] [PubMed] [Google Scholar]
- 48.Intracranial germinoma as a very rare cause of panhypopituitarism in a 23-year old man. Reisch N, Kühne-Eversmann L, Franke D, Beuschlein F, Mueller-Lisse UG, Reincke M, Seissler J. Exp Clin Endocrinol Diabetes. 2009;117:320–323. doi: 10.1055/s-0028-1100418. [DOI] [PubMed] [Google Scholar]
- 49.CNS germinoma of the pituitary and pineal regions, lateral ventricle, and fourth ventricle presenting in adulthood. Hoque R, Menon U, Gonzalez-Toledo E, Gu X, Jaffe SL. J La State Med Soc. 2008;160:319–321. [PubMed] [Google Scholar]



